Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16283570rdf:typepubmed:Citationlld:pubmed
pubmed-article:16283570lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16283570lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:16283570lifeskim:mentionsumls-concept:C0021764lld:lifeskim
pubmed-article:16283570lifeskim:mentionsumls-concept:C0004368lld:lifeskim
pubmed-article:16283570lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:16283570lifeskim:mentionsumls-concept:C1718423lld:lifeskim
pubmed-article:16283570lifeskim:mentionsumls-concept:C1511636lld:lifeskim
pubmed-article:16283570lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:16283570lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:16283570lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:16283570pubmed:issue12lld:pubmed
pubmed-article:16283570pubmed:dateCreated2005-12-5lld:pubmed
pubmed-article:16283570pubmed:abstractTextCytotoxic T lymphocyte-associated antigen (CTLA)-4 can inhibit T-cell responses and is involved in tolerance against self antigens. We previously reported autoimmune manifestations and objective cancer regressions in patients with metastatic melanoma treated with CTLA-4 blockade. The possibility of activating tumor-reactive T cells while removing inhibitory activity with CTLA-4 blockade has stimulated interest in using anti-CTLA-4 antibodies in combination with other cancer immunotherapies to improve clinical outcomes. In this study, we assessed the antitumor activity and autoimmune toxicity of CTLA-4 blockade in combination with an immune-activating stimulus, interleukin (IL)-2, in patients with metastatic melanoma.lld:pubmed
pubmed-article:16283570pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:languageenglld:pubmed
pubmed-article:16283570pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:citationSubsetIMlld:pubmed
pubmed-article:16283570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16283570pubmed:statusMEDLINElld:pubmed
pubmed-article:16283570pubmed:monthDeclld:pubmed
pubmed-article:16283570pubmed:issn1068-9265lld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:SherryRichard...lld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:TopalianSuzan...lld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:YangJames CJClld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:RosenbergStev...lld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:KammulaUdai...lld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:YellinMichael...lld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:KleinerDavidDlld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:MavroukakisSh...lld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:RoyalRichard...lld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:AttiaPeterPlld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:PhanGiao QGQlld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:HaworthLeah...lld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:MakerAjay VAVlld:pubmed
pubmed-article:16283570pubmed:authorpubmed-author:LevyCatherine...lld:pubmed
pubmed-article:16283570pubmed:issnTypePrintlld:pubmed
pubmed-article:16283570pubmed:volume12lld:pubmed
pubmed-article:16283570pubmed:ownerNLMlld:pubmed
pubmed-article:16283570pubmed:authorsCompleteYlld:pubmed
pubmed-article:16283570pubmed:pagination1005-16lld:pubmed
pubmed-article:16283570pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:meshHeadingpubmed-meshheading:16283570...lld:pubmed
pubmed-article:16283570pubmed:year2005lld:pubmed
pubmed-article:16283570pubmed:articleTitleTumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.lld:pubmed
pubmed-article:16283570pubmed:affiliationSurgery Branch, National Cancer Institute, National Institutes of Health, CRC Room 3-3940, 10 Center Drive, MSC 1201, Bethesda, MD 20814, USA.lld:pubmed
pubmed-article:16283570pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16283570pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
pubmed-article:16283570pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16283570lld:pubmed
More...